The DEA refuses to reclassify marijuana, but it is promising to make it easier for scientists and companies to get different strains of the plant for research.
The Drug Enforcement Administration announced on August 11 that marijuana would remain illegal under federal law, while remaining a Schedule I substance.
The FDA has given Oxitec Ltd. approval to conduct a trial of mosquitoes genetically engineered to fight the Zika virus in the Florida Keys.
Soybean fields in parts of Arkansas, Missouri, and Tennessee are plagued by “superweeds” that have become resistant to Monsanto’s herbicide ingredient, glyphosate.
The DEA said it would decide in the first part of 2016 whether to reschedule marijuana as a Schedule II substance. It has once again delayed that decision.
Beginning August 1, nearly 800 patients with intractable pain in Minnesota will have access to medical marijuana.
Starbucks is currently testing 100% recyclable paper cups in the UK. The coffee chain goes through 4 billion cups a year, including 2.5 billion in the UK.
Products that have been injected with foreign DNA are considered by the USDA to be genetically engineered, but not products with deleted DNA.
Citing a lack of financial resources, a marijuana-opposition group in Colorado has abandoned its efforts to limit the amount of THC in legal pot products.
On July 8, the House approved an agreement between itself and the Senate intended to tackle the burgeoning opioid crisis in America.
If California voters approve a ballot initiative in November legalizing recreational marijuana, the state stands to bring in $1 billion in taxes.
An Illinois county judge has ordered the state to include PTSD as a qualifying condition for medical marijuana following a lawsuit filed by an Iraq war vet.
A provision in the VA’s annual budget bill that would have allowed VA doctors to recommend medical marijuana to veterans was pulled at the last minute.
The Kaiser Family Foundation is warning that Obamacare insurance premiums are set to go up yet again, making life more difficult for many.
Two drug companies must pay $67 million to settle allegations that they deceptively marketed a cancer drug and gave doctors illegal kickbacks.
After hearing arguments both for and against drug advertising on TV, 57% of poll-takers said they support removing prescription drug ads from TV.
From sales drops to overall poor public image, here are 9 documented financial risks of doing business with biotech giant Monsanto.